Next Article in Journal
Membrane Localization of HspA1A, a Stress Inducible 70-kDa Heat-Shock Protein, Depends on Its Interaction with Intracellular Phosphatidylserine
Next Article in Special Issue
Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor
Previous Article in Journal
Intracellular Peptides in Cell Biology and Pharmacology
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessArticle

Regulation of the Expression of DAPK1 by SUMO Pathway

Provincial University Key Laboratory of Cellular Stress Response and Metabolic Regulation, College of Life Sciences, Fujian Normal University, Fuzhou 350117, China
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Imam Abdulrahman bin Faisal University, Dammam 34212, Saudi Arabia
School of Applied Sciences, Edinburgh Napier University, Edinburgh EH11 4BN, UK
Institute of Genetics and Molecular Medicine, Cell Signaling Unit, CRUK p53 Transduction Group, University of Edinburgh, EH4 2XR EH4 2XR, UK
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Biomolecules 2019, 9(4), 151;
Received: 15 March 2019 / Revised: 7 April 2019 / Accepted: 15 April 2019 / Published: 17 April 2019
PDF [3186 KB, uploaded 22 April 2019]


Death Associated Protein Kinase 1 (DAPK1) is an important signaling kinase mediating the biological effect of multiple natural biomolecules such as IFN-γ, TNF-α, curcumin, etc. DAPK1 is degraded through both ubiquitin-proteasomal and lysosomal degradation pathways. To investigate the crosstalk between these two DAPK1 degradation pathways, we carried out a screen using a set of ubiquitin E2 siRNAs at the presence of Tuberous Sclerous 2 (TSC2) and identified that the small ubiquitin-like molecule (SUMO) pathway is able to regulate the protein levels of DAPK1. Inhibition of the SUMO pathway enhanced DAPK1 protein levels and the minimum domain of DAPK1 protein required for this regulation is the kinase domain, suggesting that the SUMO pathway regulates DAPK1 protein levels independent of TSC2. Suppression of the SUMO pathway did not enhance DAPK1 protein stability. In addition, mutation of the potential SUMO conjugation sites on DAPK1 kinase domain did not alter its protein stability or response to SUMO pathway inhibition. These data suggested that the SUMO pathway does not regulate DAPK1 protein degradation. The exact molecular mechanism underlying this regulation is yet to be discovered. View Full-Text
Keywords: DAPK1; SUMO; SENP; protein degradation; post-translational modification DAPK1; SUMO; SENP; protein degradation; post-translational modification

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Wang, Q.; Zhang, X.; Chen, L.; Weng, S.; Xia, Y.; Ye, Y.; Li, K.; Liao, Z.; Chen, P.; Alsamman, K.; Meng, C.; Stevens, C.; Hupp, T.R.; Lin, Y. Regulation of the Expression of DAPK1 by SUMO Pathway. Biomolecules 2019, 9, 151.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Biomolecules EISSN 2218-273X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top